Randomized trial of whey protein to prevent colorectal neoplasia
Not Applicable
- Conditions
- colorectal neoplasia
- Registration Number
- JPRN-UMIN000032746
- Lead Sponsor
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University Katsushika Medical Center
- Brief Summary
The study was terminated because it was not possible to collect cases due to Covid-19 infection.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.Person who is under 20 years old 2.Person who is taking laxative, prostaglandin analog or NSAIDs 3.Person who has allergy for dairy products
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method After taking whey protein for 1 year, the prevention of colorectal neoplasia will be examined with colonoscopy.
- Secondary Outcome Measures
Name Time Method Adverse events due to taking whey protein will be assessed in blood tests after 6 months and 1 year.